Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2010
Neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor: results of a phase II trial in patients with advanced non-small-cell lung cancer
Lecia V Sequist, Benjamin Besse, Thomas J Lynch, et al.
Health Technology Assessment (Winchester, England)
|
May 26, 2015
An external pilot study to test the feasibility of a randomised controlled trial comparing eye muscle surgery against active monitoring for childhood intermittent exotropia [X(T)]
Michael Clarke, Vanessa Hogan, Deborah Buck, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
June 23, 2009
Randomized controlled trial of feeding a concentrated formula to infants born to women infected by human immunodeficiency virus
Harland S Winter, James M Oleske, Michael D Hughes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2010
Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancer
Harold J Burstein, Yan Sun, Luc Y Dirix, et al.
Research Square
|
November 1, 2024
Refractory testicular germ cell tumors are highly sensitive to the targeting of polycomb pathway demethylases KDM6A and KDM6B
Doha Shokry, Mehwish W Khan, Christine Powell, et al.
Cell Communication and Signaling : CCS
|
November 1, 2024
Refractory testicular germ cell tumors are highly sensitive to the targeting of polycomb pathway demethylases KDM6A and KDM6B
Doha Shokry, Mehwish W Khan, Christine Powell, et al.
Cardiovascular Drugs and Therapy
|
February 17, 2020
Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)
Daniel P Judge, Arnt V Kristen, Martha Grogan, et al.
Cardiovascular Drugs and Therapy
|
June 18, 2020
Correction to: Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)
Daniel P Judge, Arnt V Kristen, Martha Grogan, et al.
Translational Vision Science & Technology
|
March 6, 2019
ASTEROID: A New Clinical Stereotest on an Autostereo 3D Tablet
Kathleen Vancleef, Ignacio Serrano-Pedraza, Craig Sharp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2009
A phase I study with neratinib (HKI-272), an irreversible pan ErbB receptor tyrosine kinase inhibitor, in patients with solid tumors
Kwok-K Wong, Paula M Fracasso, Ronald M Bukowski, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2010
Neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor: results of a phase II trial in patients with advanced non-small-cell lung cancer
Lecia V Sequist, Benjamin Besse, Thomas J Lynch, et al.
Health Technology Assessment (Winchester, England)
|
May 26, 2015
An external pilot study to test the feasibility of a randomised controlled trial comparing eye muscle surgery against active monitoring for childhood intermittent exotropia [X(T)]
Michael Clarke, Vanessa Hogan, Deborah Buck, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
June 23, 2009
Randomized controlled trial of feeding a concentrated formula to infants born to women infected by human immunodeficiency virus
Harland S Winter, James M Oleske, Michael D Hughes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2010
Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancer
Harold J Burstein, Yan Sun, Luc Y Dirix, et al.
Research Square
|
November 1, 2024
Refractory testicular germ cell tumors are highly sensitive to the targeting of polycomb pathway demethylases KDM6A and KDM6B
Doha Shokry, Mehwish W Khan, Christine Powell, et al.
Cell Communication and Signaling : CCS
|
November 1, 2024
Refractory testicular germ cell tumors are highly sensitive to the targeting of polycomb pathway demethylases KDM6A and KDM6B
Doha Shokry, Mehwish W Khan, Christine Powell, et al.
Cardiovascular Drugs and Therapy
|
February 17, 2020
Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)
Daniel P Judge, Arnt V Kristen, Martha Grogan, et al.
Cardiovascular Drugs and Therapy
|
June 18, 2020
Correction to: Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)
Daniel P Judge, Arnt V Kristen, Martha Grogan, et al.
Translational Vision Science & Technology
|
March 6, 2019
ASTEROID: A New Clinical Stereotest on an Autostereo 3D Tablet
Kathleen Vancleef, Ignacio Serrano-Pedraza, Craig Sharp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2009
A phase I study with neratinib (HKI-272), an irreversible pan ErbB receptor tyrosine kinase inhibitor, in patients with solid tumors
Kwok-K Wong, Paula M Fracasso, Ronald M Bukowski, et al.
Page
of 4